AU2001232332A1 - Leptin-resistance ameliorating agents - Google Patents

Leptin-resistance ameliorating agents

Info

Publication number: AU2001232332A1
Authority: AU; Australia
Prior art keywords: leptin; ameliorating agents; resistance ameliorating; resistance; agents
Prior art date: 2000-03-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001232332A

Inventor

Tsutomu Nakagawa

Mutsuo Taiji

Mitsugu Yamanaka

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sumitomo Pharma Co Ltd

Original Assignee

Sumitomo Pharmaceuticals Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-06

Filing date

2001-02-19

Publication date

2001-09-17

2001-02-19 Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd

2001-09-17 Publication of AU2001232332A1 publication Critical patent/AU2001232332A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Immunology (AREA)
Endocrinology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Zoology (AREA)
Psychology (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2001232332A 2000-03-06 2001-02-19 Leptin-resistance ameliorating agents Abandoned AU2001232332A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000-60458		2000-03-06
JP2000060458		2000-03-06
PCT/JP2001/001149 WO2001066133A1 (en)	2000-03-06	2001-02-19	Leptin-resistance ameliorating agents

Publications (1)

Publication Number	Publication Date
AU2001232332A1 true AU2001232332A1 (en)	2001-09-17

Family

ID=18580771

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001232332A Abandoned AU2001232332A1 (en)	2000-03-06	2001-02-19	Leptin-resistance ameliorating agents

Country Status (4)

Country	Link
US (1)	US20030036512A1 (en)
EP (1)	EP1262189A1 (en)
AU (1)	AU2001232332A1 (en)
WO (1)	WO2001066133A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007523196A (en) *	2004-02-20	2007-08-16	ライナットニューロサイエンスコーポレイション	Method for treating obesity or diabetes using NT-4 / 5
WO2005085846A1 (en) *	2004-03-03	2005-09-15	Daiichi Pure Chemicals Co., Ltd.	Diagnostic for ischemic heart disease risk group
EP1779861A1 (en) *	2005-10-26	2007-05-02	Staidson (Beijing) Pharmaceutical Co., LTD	Use of nerve growth factor (NGF) for the preparation of a medicament for the stimulation of weight loss
EP1988920A1 (en) *	2006-02-02	2008-11-12	Rinat Neuroscience Corp.	Methods for treating obesity by administering a trkb antagonist
CA2637826A1 (en) *	2006-02-02	2007-08-09	Rinat Neuroscience Corporation	Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist
MX2009006794A (en) *	2006-12-20	2009-07-02	Rinat Neuroscience Corp	Trkb agonists for treating autoimmune disorders.
WO2010086828A2 (en) *	2009-02-02	2010-08-05	Rinat Neuroscience Corporation	Agonist anti-trkb monoclonal antibodies
KR101811797B1 (en) *	2013-04-03	2017-12-22	동국제약 주식회사	Pharmaceutical composition comprising donepezil for parenteral administration
JP7699432B2 (en) *	2020-12-08	2025-06-27	小林製薬株式会社	Appetite regulating hormone secretion normalizer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5229500A (en) *	1989-08-30	1993-07-20	Regeneron Pharmaceuticals, Inc.	Brain derived neurotrophic factor
IT1288388B1 (en) *	1996-11-19	1998-09-22	Angeletti P Ist Richerche Bio	USE OF SUBSTANCES THAT ACTIVATE THE CNTF RECEPTOR (NEUROTROPHIC CHILI FACTOR) FOR THE PREPARATION OF DRUGS FOR THERAPY
WO1998032458A1 (en) *	1997-01-23	1998-07-30	Sumitomo Pharmaceuticals Company, Limited	Remedies for diabetes
JPH10279500A (en) *	1997-04-04	1998-10-20	Sumitomo Pharmaceut Co Ltd	Obesity treatment
CA2339833A1 (en) *	1998-08-11	2000-02-24	Sumitomo Pharmaceuticals Company Limited	Blood sugar level controlling agent

2001
- 2001-02-19 AU AU2001232332A patent/AU2001232332A1/en not_active Abandoned
- 2001-02-19 WO PCT/JP2001/001149 patent/WO2001066133A1/en not_active Ceased
- 2001-02-19 US US10/220,852 patent/US20030036512A1/en not_active Abandoned
- 2001-02-19 EP EP01904528A patent/EP1262189A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP1262189A1 (en)	2002-12-04
WO2001066133A1 (en)	2001-09-13
US20030036512A1 (en)	2003-02-20

Publication	Publication Date	Title
AU2001288040A1 (en)	2002-03-26	Homeostasis-maintaining agents
AU2001262847A1 (en)	2001-12-11	Language-understanding
AU2002214284A1 (en)	2002-05-27	Anti-helicobacterial agents
AU2001292739A1 (en)	2002-04-08	1-oxorapamycins
AU2001254546A1 (en)	2001-11-07	Aminopiperidines
AU2000267458A1 (en)	2001-10-15	Hypercomputer
AU2001220246A1 (en)	2001-12-11	Neckphone
AU2001239310A1 (en)	2001-10-03	Decahydro-isoquinolines
AU2001296577A1 (en)	2002-04-15	Chlorophyllases
AU2001258349A1 (en)	2001-11-26	Bisacylguanidine
EP1151667A3 (en)	2003-01-29	Plant-activating agent
AU2001279754A1 (en)	2002-01-30	Indoloquinazolinones
AU2002211128A1 (en)	2002-04-22	Step-bike
AU2001290931A1 (en)	2002-03-26	Ski-snowboard
AU2001285886A1 (en)	2002-03-22	2-guanidino-4-aryl-quinazoline
AU2001258924A1 (en)	2001-11-26	Microsatellite-aflp
AU2001293852A1 (en)	2002-06-27	Sulfonylguanidine
AU2001248788A1 (en)	2001-11-07	Glucuronofucan sulfate
AU2001232332A1 (en)	2001-09-17	Leptin-resistance ameliorating agents
AU2001281921A1 (en)	2002-01-08	Bdellosomes
AU2001291876A1 (en)	2002-06-20	Triazolo-epothilones
AU2001246864A1 (en)	2002-01-10	Hypotensors
AU2001226668A1 (en)	2001-09-12	Crankshaft-starter-generator
AU4620300A (en)	2001-09-24	Can
AU2001284173A1 (en)	2002-03-04	Calycins